ATE232397T1 - Neuartige orale zubereitungen von calcitonin - Google Patents

Neuartige orale zubereitungen von calcitonin

Info

Publication number
ATE232397T1
ATE232397T1 AT97950098T AT97950098T ATE232397T1 AT E232397 T1 ATE232397 T1 AT E232397T1 AT 97950098 T AT97950098 T AT 97950098T AT 97950098 T AT97950098 T AT 97950098T AT E232397 T1 ATE232397 T1 AT E232397T1
Authority
AT
Austria
Prior art keywords
calcitonin
oral preparations
novel oral
novel
preparations
Prior art date
Application number
AT97950098T
Other languages
English (en)
Inventor
Matteo Ghirri
Marco Zema
Original Assignee
Eurand Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Int filed Critical Eurand Int
Application granted granted Critical
Publication of ATE232397T1 publication Critical patent/ATE232397T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT97950098T 1996-11-07 1997-11-05 Neuartige orale zubereitungen von calcitonin ATE232397T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9623205.3A GB9623205D0 (en) 1996-11-07 1996-11-07 Novel pharmaceutical compositions
PCT/EP1997/006104 WO1998019697A2 (en) 1996-11-07 1997-11-05 Novel pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE232397T1 true ATE232397T1 (de) 2003-02-15

Family

ID=10802593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97950098T ATE232397T1 (de) 1996-11-07 1997-11-05 Neuartige orale zubereitungen von calcitonin

Country Status (15)

Country Link
US (1) US6352974B1 (de)
EP (1) EP0966299B1 (de)
JP (1) JP2001511114A (de)
AR (1) AR010554A1 (de)
AT (1) ATE232397T1 (de)
AU (1) AU5317598A (de)
CA (1) CA2270927A1 (de)
CO (1) CO4930284A1 (de)
DE (1) DE69719083T2 (de)
DK (1) DK0966299T3 (de)
ES (1) ES2192704T3 (de)
GB (1) GB9623205D0 (de)
PT (1) PT966299E (de)
WO (1) WO1998019697A2 (de)
ZA (1) ZA9710006B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3556400A (en) 1999-03-17 2000-10-04 Novartis Ag Pharmaceutical compositions
EP2206720A1 (de) * 2000-04-12 2010-07-14 Human Genome Sciences, Inc. Albuminfusionsproteine
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US7713932B2 (en) * 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
ITRM20010380A1 (it) * 2001-07-02 2003-01-02 Bioprogress Spa Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
MXPA06000807A (es) * 2003-07-23 2006-08-23 Novartis Ag Uso de calcitonina en osteoartritis.
WO2006124047A2 (en) * 2004-08-13 2006-11-23 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
US7581403B2 (en) * 2005-04-15 2009-09-01 Deeks Daniel H Energy storage arrangement
AU2006236006B2 (en) * 2006-04-13 2012-09-06 The University Of Queensland Cyclised a-conotoxin peptides
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
JP5966202B2 (ja) * 2007-02-20 2016-08-10 アラガン ファーマシューティカルズ インターナショナル リミテッド 安定な消化酵素組成物
US20090117180A1 (en) * 2007-02-20 2009-05-07 Giovanni Ortenzi Stable digestive enzyme compositions
US20090011079A1 (en) * 2007-07-02 2009-01-08 Bestsweet, Inc. Hard Coated Confectionary Having A Consumable Soft Chewing Core With An Active And Method For Making Same
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
ES2657673T3 (es) 2010-10-01 2018-03-06 Aptalis Pharma Limited Formulaciones recubiertas entéricas de pancrelipasa, de baja intensidad
CA2843556A1 (en) 2011-08-08 2013-02-14 Aptalis Pharma Ltd. Method for dissolution testing of solid compositions containing digestive enzymes
US10184121B2 (en) 2013-06-28 2019-01-22 Allergan Pharmaceuticals International Limited Methods for removing viral contaminants from pancreatic extracts
CA2920844A1 (en) 2013-08-09 2015-02-12 Allergan Pharmaceuticals International Limited Digestive enzyme composition suitable for enteral administration

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
JP2514249B2 (ja) * 1989-05-23 1996-07-10 帝人株式会社 安定化されたカルシトニン類医薬組成物
DE4119140C2 (de) * 1991-06-11 1994-05-11 Merz & Co Gmbh & Co Poröser, in Körperflüssigkeiten und Sekreten löslicher, spongoider Formkörper, dessen Herstellung und Verwendung
JPH08225454A (ja) * 1995-02-23 1996-09-03 Chugai Pharmaceut Co Ltd マイクロスフェア製剤

Also Published As

Publication number Publication date
EP0966299A2 (de) 1999-12-29
ZA9710006B (en) 1999-06-05
CO4930284A1 (es) 2000-06-27
DK0966299T3 (da) 2003-06-02
PT966299E (pt) 2003-06-30
EP0966299B1 (de) 2003-02-12
WO1998019697A3 (en) 1998-07-16
JP2001511114A (ja) 2001-08-07
ES2192704T3 (es) 2003-10-16
CA2270927A1 (en) 1998-05-14
DE69719083D1 (de) 2003-03-20
DE69719083T2 (de) 2003-12-18
US6352974B1 (en) 2002-03-05
AR010554A1 (es) 2000-06-28
GB9623205D0 (en) 1997-01-08
AU5317598A (en) 1998-05-29
WO1998019697A2 (en) 1998-05-14

Similar Documents

Publication Publication Date Title
DE69429359D1 (de) Orale zubereitungen von antimykotika
DE19681287T1 (de) Orale Formulierung von 2-Methylthienobenzodiazepin
DE69518331D1 (de) Orale zubereitungen
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
ATE253371T1 (de) Formulierungen von clarithromycin mit verlängerter wirkstoff-freisetzung
DE69833739D1 (de) Kosmetisches Präparat
KR950703926A (ko) 화장제 조성물(Cosmetic Composition)
DE69329764D1 (de) Neues kosmetisches präparat
DE69625368D1 (de) Schweisshemmende deodorierende präparaten
ATE223696T1 (de) Kosmetische präparate
ATE239011T1 (de) Neuartige form von s-omeprazol
ATE176383T1 (de) Dermal applizierbare formulierungen von parasitiziden
DE59710701D1 (de) Kosmetische zubereitungen
NO983581D0 (no) Lysfiltrerende kosmetisk sammensetning
DE69415340D1 (de) Kosmetisches präparat
DE59804418D1 (de) Kosmetische zubereitungen
DE69804630D1 (de) Reindarstellung von propylenoxid
DE69719083D1 (de) Neuartige orale Zubereitungen von Calcitonin
DE69703584D1 (de) Kaskadierter anschluss von kommunizierenden geräte
KR970000228A (ko) S-에토돌락의 경구용 제제
DE59709718D1 (de) Kosmetische zubereitungen
DE69518464D1 (de) Verdickte kosmetische Zubereitungen
DE59707298D1 (de) Desodorierende zubereitungen
DE69432149D1 (de) Orale Zubereitungen
DE69834091D1 (de) Kosmetische Zubereitung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0966299

Country of ref document: EP

REN Ceased due to non-payment of the annual fee